Member Info for inanaco

36m market cap ....

when we have a proven platform to produce High Avidity T cells and antibodies ...

i think some forget that we have a leap in TCR technology over the last 2 years .. able to now extract "natural T cells" that have engaged this virus and pull out the Binding element .... the TCR

we certainly have an edge ......

TF it was the BUT in capitals ... which i objected to ...

plenty of scope then ...

She said: "We haven't at the moment got a vaccine so we're having to start from scratch. And we don't have a hugely good track record with vaccines for this virus or family of viruses."

Dominic Raab has warned that a coronavirus vaccine is "not likely to come to fruition this year".

Speaking to Sophy Ridge on Sky News, he said: “We are looking at the possibility of a vaccine - that’s not likely to come to fruition this year but it could be very important if there are multiple waves of coronavirus globally further down the track”.

His words were also echoed by Gina Radford, the former deputy Chief Medical Officer. Earlier today she argued that the public needed to be "realistic" about the time needed to produce a coronavirus vaccine and that it may not be ready "until well into next year."

She said: "We haven't at the moment got a vaccine so we're having to start from scratch. And we don't have a hugely good track record with vaccines for this virus or family of viruses."

Most experts believe there will not be a vaccine until "well into next year," she continued, but with research from Oxford University being sped up, "you never know".

C7
we are not in that field mate, scancell will look at immune responses via other means as we need a far more accurate answer's than yes or no ...
Accurate answer's are time consuming which is why only high level investigations get access to Porton Down ie the current research on estimated numbers that have had the decease and recovered .. antibody testing at this level its very expensive

well i have nibbled beyond 700,000 ........ i bought another £2k at 5.33 last week ..

so to all those that want to moan ..........

BUT .............. its only 8p

yes crumbs and Scancell has considered the market is open for a Vaccine that is a bit more universal and can encompass future mutations .... and has the potency to yield immunity in all ages ....

today its a punt at 8p ....

but look on the bright side ..

avidmab
Moditope
Immunobody

£36m mcap ...

if you are an investor ....

the word BUT ... is meaningless ...

because you Hold or you Dont ...

so you are in or out ...

BUT, if for those that worry about a holding then really they should be not on the exchange or should invest in water companies .. or something far less dramatic

Tf ... trust you to turn it all negative ...
capital letters

BUT ....

Once we have found Partners with Deep Pockets ...
The share will Fly ...........

ATB

we know the share is cheap ............. ATB

its all about Risk ..........

The world economy is collapsing ...............

the risk of not building an immunobody is way higher ... than building one ...

Take another shot
Developing mRNA vaccines is not always straightforward, however. Moderna’s initial candidate vaccine for Zika virus, for example, was well tolerated in people but failed to provoke much of an immune response. With funding from the US government, Moderna went back to the lab, optimized the vaccine sequence and developed another candidate that is, according to Zaks, “at least 20 times more potent” than the first-generation product in mice and monkey testing.

I like this chap ............ Says it, as he see's it .... who else does that ?

Ruck elevates Covid to "supernatural "

Jonathan Ball
@JonathanKBall
·
14h
How does
@WHO
propose to navigate through this conundrum. Not sure that questioning if protective immunity was elicited in people recovered from #Covid19 is right; sure duration of protection important but we shouldn’t elevate SARS2 to supernatural levels

High Dose and Adjuvanted Flu Vaccine Side Effects

The high dose and adjuvanted flu vaccines may result in more of the temporary, mild side effects that can occur with standard-dose seasonal shots. Side effects can include pain, redness or swelling at the injection site, headache, muscle ache and malaise, and typically resolve with 1 to 3 days.

More information about different types of flu vaccines can be found

Covid has to be potent in the 55 age group ............ or it just won't be of benefit ..

https://www.cdc.gov/flu/highrisk/65over.htm

I give up ......................... funny how the over 65's ... get a far more potent vaccine

Types of Flu Shots for People 65 and Older
People 65 years and older should get a flu shot and not a nasal spray vaccine. They can get any flu vaccine approved for use in that age group with no preference for any one vaccine over another. There are regular flu shots that are approved for use in people 65 years and older and there also are two vaccines designed specifically for people 65 years and older:

Bermuda ..... so why does Professor Jonathan Ball need Scancell ?

after all you posted

""""Also worth noting that Scancell simply don't have a vaccine platform that can be quickly developed and manufactured yet and at the moment speed is of the essence, hence the focus on mRNA vaccines.""""

that is the point Crumbs those natives that survived a new virus confer some immunity to the off spring .... and on it goes

Darwin ...

and they have no proof it does not ..................

that is a time issue ...

or should we all self isolate for Life ..................... because CoVid has beaten Darwin ...